P2

• Arteries are muscular-walled blood vessels designed to carry oxygenated blood away from the heart under high intravascular pressures.

• Arteriosclerosis refers to the general thickening, hardening, and loss of elasticity of the arterial walls, leading to arterial narrowing.

• Atherosclerosis is a specific form of arteriosclerosis characterized by the subendothelial accumulation of lipid-rich plaques on the inner arterial lumen.

• The arterial wall is organized into three distinct concentric layers:

  • Tunica Intima:

  • The innermost lining in direct contact with circulating blood.

  • Composed of a continuous monolayer of endothelial cells resting upon an extracellular basement membrane.

  • Endothelial cell injury and dysfunction within this layer serve as the primary inciting events in both arteriosclerosis and atherosclerosis.

  • Tunica Media:

  • The intermediate and thickest structural layer, composed predominantly of vascular smooth muscle cells and elastic fibers.

  • Modulates vascular resistance, tone, and luminal caliber to regulate systemic blood flow.

  • Autonomic neural regulation:

    • Alpha-adrenergic receptor stimulation induces vascular smooth muscle contraction resulting in arterial vasoconstriction.

    • Beta-adrenergic receptor stimulation promotes vascular smooth muscle relaxation resulting in arterial vasodilation.

  • Calcium ($Ca^{2+}$) entry into smooth muscle cells triggers vascular contraction and vasoconstriction; calcium channel blockers pharmacologically inhibit this influx to promote arterial vasodilation.

  • Tunica Externa (Adventitia):

  • The outermost protective sheath of the arterial vessel.

  • Composed of fibrous connective tissue that anchors the vessel to adjacent histological structures.

Vascular Endothelium Physiology and Secretory Function

• The vascular endothelium is a metabolically active and endocrine-responsive paracrine tissue, rather than an inert mechanical barrier.

• Key physiological duties of endothelial cells include:

  • Mediating selective fluid and solute filtration across the vascular wall.

  • Maintaining baseline vascular smooth muscle tone and tissue perfusion.

  • Serving as a semipermeable interface between systemic circulation and interstitial spaces.

  • Coordinating leukocyte recruitment and neutrophil chemotaxis toward sites of vascular injury or pathogen invasion.

  • Synthesizing and secreting bioactive signaling molecules that govern vasomotor tone and hemostasis.

• Major endothelial-derived biochemical mediators:

  • Nitric Oxide (NO):

  • Primary endogenous vasodilator.

  • Diffuses into the tunica media to induce smooth muscle relaxation and luminal widening.

  • Endothelin:

  • Potent endogenous peptide that triggers arterial vasoconstriction and augments vascular tone.

  • Vascular Endothelial Growth Factor (VEGF):

  • Angiogenic signaling protein that stimulates new capillary sprouting and collateral blood vessel growth.

  • C-type Natriuretic Peptide:

  • Induces vascular smooth muscle relaxation and promotes renal sodium and water diuresis.

  • Prostacyclin ($\text{PGI}_2$):

  • Potent antiplatelet and antithrombotic lipid mediator that inhibits platelet aggregation and prevents inappropriate clotting.

  • Thromboxane A2 ($\text{TXA}_2$):

  • Eicosanoid released during injury that activates platelets and stimulates thrombosis alongside vasoconstriction.

  • von Willebrand Factor (vWF):

  • Glycoprotein that tethers platelets to exposed subendothelial collagen, activating the primary hemostatic clotting cascade.

Hemodynamics and Arterial Wall Mechanics

• Laminar versus Turbulent Blood Flow:

  • Laminar Flow:

  • The optimal, frictionless state of circulation wherein concentric layers of blood slide smoothly parallel to the longitudinal axis of the vessel lumen.

  • Characterized by parabolic flow velocity, with the fastest velocity situated in the central stream and minimal friction along the endothelial surface.

  • Turbulent Flow:

  • A disordered, chaotic flow profile wherein blood moves perpendicular to the vessel axis, creating vortices and eddies.

  • Induced by structural changes including endothelial damage, atherosclerotic plaques, arterial branch bifurcations, or sudden stenoses.

  • Auscultated clinically as a characteristic whooshing vascular sound termed a bruit (e.g., carotid or femoral bruit).

  • Precipitates localized hemodynamic stasis, high shear stress, and micro-injury, significantly elevating the risk of intravascular thrombus formation.

• Arterial Wall Tension and Compliance:

  • Arterial Wall Tension: The mechanical opposing force generated within the vessel wall to resist the internal distending intravascular pressure.

  • In sustained hypertension (HTN), chronic high shear stress prompts smooth muscle hypertrophy and extracellular matrix remodeling, increasing wall thickness to offset wall stress.

  • Vascular Compliance: The structural ability of an arterial vessel to distend and accommodate increases in blood volume without excessive spikes in intraluminal pressure; compliance decreases markedly with arteriosclerosis.

Hemodynamic Principles and Blood Pressure Regulation

• Core Cardiac Hemodynamic Parameters:

  • Systole: The phase of the cardiac cycle defined by ventricular contraction and mechanical ejection of blood into the systemic aorta.

  • Diastole: The phase of ventricular relaxation and ventricular filling.

  • Systolic Blood Pressure (SBP): Peak mechanical pressure exerted against arterial walls during ventricular systole.

  • Diastolic Blood Pressure (DBP): Baseline hydrostatic pressure retained in the arterial system during ventricular diastole.

  • Pulse Pressure: The arithmetic difference between systolic and diastolic blood pressure:

  • $\text{Pulse Pressure} = \text{SBP} - \text{DBP}$

  • An ideal, normative resting pulse pressure is approximately $40\,\text{mm\,Hg}$.

  • Stroke Volume (SV): The volume of blood ejected by the left ventricle per single mechanical cardiac contraction (measured in $\text{mL}$; standard resting value is $\approx 70\,\text{mL/beat}$).

  • Cardiac Output (CO): The total volume of blood pumped through the systemic vasculature per minute:

  • $\text{CO} = \text{Heart Rate (HR)} \times \text{Stroke Volume (SV)}$

  • Normal baseline cardiac output is approximately $5\,\text{L/min}$ at rest:

    • $70\,\text{bpm} \times 70\,\text{mL/beat} = 4.9\,\text{L/min}$

• Mathematical Relationships of Blood Pressure:

  • Systemic arterial blood pressure is governed by cardiac output and total peripheral vascular resistance (PVR):

  • $\text{CO} = \frac{\text{BP}}{\text{PVR}}$

  • $\text{BP} = \text{CO} \times \text{PVR}$

  • Autonomic nervous system (ANS) innervation directly alters PVR by dynamically modulating precapillary arteriolar caliber.

  • Elevations in systemic blood pressure are physiologically achieved through two core mechanisms:

  • Increasing Cardiac Output (via elevated heart rate and/or expanded stroke volume).

  • Increasing Peripheral Vascular Resistance (via widespread systemic vasoconstriction).

• Baroreceptors and Neural BP Control:

  • Specialized mechanoreceptors located within the carotid sinus and aortic arch that detect transient stretches of the vascular wall.

  • Responsible for rapid, short-term blood pressure maintenance (e.g., transitioning from a supine to an erect posture).

  • Project afferent sensory inputs directly to cardioregulatory centers located within the medulla oblongata and pons:

  • When Blood Pressure Rises Excessively:

    • Baroreceptor firing activates the parasympathetic nervous system (PNS).

    • Induces bradycardia (decreased HR), reduced myocardial contractility, and widespread peripheral vasodilation.

  • When Blood Pressure Drops Critically:

    • Baroreceptor unloading diminishes inhibitory afferent signaling, prompting sympathetic nervous system (SNS) surge.

    • Induces tachycardia (increased HR), increased inotropy, and arterial vasoconstriction to stabilize mean arterial pressure.

• Orthostatic Hypotension:

  • A sudden drop in systemic blood pressure upon transitioning abruptly from a supine or seated position to standing.

  • Venous pooling within lower extremities compromises venous return, transiently diminishing cardiac output and cerebral perfusion pressure, causing dizziness, lightheadedness, or syncope.

  • Compensatory baroreceptor activation triggers an immediate SNS surge to elevate heart rate and induce peripheral vasoconstriction to restore cerebral perfusion.

• Renin-Angiotensin-Aldosterone System (RAAS):

  • A vital hormonal cascade activated by renal hypoperfusion or systemic hypotensive states:

  1. Juxtaglomerular (JG) cells of the renal afferent arterioles detect low perfusion pressure and synthesize and secrete renin.

  2. Circulating renin cleaves hepatic-derived angiotensinogen into angiotensin I.

  3. Angiotensin I traverses the pulmonary microvasculature, where Angiotensin-Converting Enzyme (ACE) hydrolyzes it into angiotensin II.

  4. Angiotensin II acts directly as a potent systemic vasoconstrictor to acutely elevate PVR and stimulates the adrenal cortex to synthesize and release aldosterone.

  5. Aldosterone binds to collecting tubules within the nephron, stimulating active sodium ($\text{Na}^+$) reabsorption, passive water retention, and potassium ($\text{K}^+$) excretion.

  6. The combination of intense arteriolar vasoconstriction and expanding extracellular circulating fluid volume elevates systemic blood pressure.

• Antidiuretic Hormone (ADH / Vasopressin):

  • Synthesized by the hypothalamus and stored/secreted by the posterior pituitary gland.

  • Released in response to systemic hypovolemia, hypotensive shock, or elevated serum osmolarity detected by central osmoreceptors.

  • Directly increases water permeability and reabsorption within the collecting ducts of renal nephrons without altering electrolyte excretion.

  • Expands intravascular blood volume and elevates systemic blood pressure.

• Endogenous Natriuresis:

  • Counter-regulatory physiological mechanisms that enhance renal sodium and water loss when circulating blood volume and atrial pressures exceed normal thresholds:

  • Atrial Natriuretic Peptide (ANP): Synthesized and secreted by atrial myocytes in response to sustained hypervolemia and excessive atrial wall stretch.

  • B-type (Brain) Natriuretic Peptide (BNP): Released by ventricular myocardium when exposed to excessive diastolic volume overload and stretch.

  • Both peptides promote renal diuresis and systemic vasodilation to alleviate elevated preload and reduce arterial blood pressure.

Blood Composition, Atherogenic Risk Factors, and Lipid Metabolism

• Systemic Circulatory Factors Damaging the Arterial Endothelium:

  • Lipids (Cholesterol and Triglycerides):

  • Elevated levels of low-density lipoprotein (LDL, the "bad cholesterol") lead to endothelial subintimal lipid retention and oxidation.

  • Catalyzes atherosclerotic plaque formation, precipitating coronary artery disease (CAD), myocardial infarction, and ischemic stroke.

  • Elevated Serum Glucose:

  • Chronic hyperglycemia (as observed in poorly controlled diabetes mellitus) chemically glycosylates endothelial proteins.

  • Induces structural stiffening, persistent oxidative stress, endothelial denudation, and rapid development of diffuse atherosclerotic lesions.

  • Free Radicals:

  • Reactive oxygen species (ROS) amplified by cigarette smoke exposure, environmental toxins, and diets dense in saturated fats.

  • Directly degrade cell membrane lipids via lipid peroxidation and deplete endogenous nitric oxide, maintaining vascular inflammation.

  • Nicotine:

  • Exogenous alkaloid delivered by combustible and electronic tobacco products.

  • Exerts potent neurosympathetic vasoconstrictive action, raises systemic arterial blood pressure, and causes endothelial cytotoxicity.

  • Homocysteine:

  • Intermediate amino acid produced during methionine metabolism.

  • Hyperhomocysteinemia directly damages endothelial integrity and accelerates thrombosis; closely associated with nutritional deficiencies in vitamin $B_{12}$ and folic acid.

• Hyperlipidemia and Dyslipidemia:

  • Hyperlipidemia encompasses elevated concentrations of systemic lipids, including hypercholesterolemia (elevated cholesterol) and hypertriglyceridemia (elevated triglycerides).

  • Dyslipidemia specifically represents a pathophysiological lipid imbalance: elevated total serum cholesterol, high LDL, elevated triglycerides, and decreased levels of protective high-density lipoprotein (HDL).

  • Etiological and predisposing risk factors for hyperlipidemia:

  • Familial hypercholesterolemia (FH): Genetic mutation impairing hepatic LDL clearance.

  • Diabetes mellitus.

  • Clinical obesity.

  • Untreated hypothyroidism.

  • Sedentary lifestyle and lack of physical exercise.

  • Nutritional diets heavy in saturated and trans fats.

  • Specific dyslipidemic medications.

• Hepatic Cholesterol Synthesis and Pharmacological Mechanisms:

  • The liver regulates systemic lipid balance by synthesizing very-low-density lipoproteins (VLDL, which carry endogenous triglycerides) and utilizing hepatic low-density lipoprotein (LDL) receptors to clear circulating LDL particles.

  • Target sites for lipid-lowering pharmacotherapies include:

  • HMG-CoA Reductase Inhibitors (Statins, e.g., lovastatin): Competitively block HMG-CoA reductase, the rate-limiting enzyme in hepatic de novo cholesterol biosynthesis, lowering cellular cholesterol and upregulating surface LDL receptors.

  • ATP Citrate Lyase Inhibitors (e.g., bempedoic acid): Inhibit enzymatic cholesterol synthesis upstream of HMG-CoA reductase in the liver, stimulating increased hepatic LDL receptor density.

  • PCSK9 Inhibitors (e.g., evolocumab): Monoclonal antibodies that block the proprotein convertase subtilisin/kexin type 9 (PCSK9) enzyme from targeting hepatic LDL receptors for lysosomal degradation; increasing surviving LDL receptors on hepatocytes reduces circulating serum LDL.

  • Fibrates (e.g., gemfibrozil): Downregulate hepatic VLDL secretion, lower circulating triglyceride pools, and stimulate peripheral lipoprotein lipolysis.

  • Omega-3 Fatty Acids (e.g., fish oils): Directly decrease circulating serum triglyceride concentrations.

  • Bile Acid Sequestrants (e.g., cholestyramine): Bind bile acids (cholesterol-derived compounds) within the ileal lumen to prevent enterohepatic reabsorption, promoting biliary fecal excretion and driving hepatic conversion of cholesterol into bile acids.

Systemic Hypertension: Epidemiology, Pathology, and Complications

• Diagnostic Criteria and Staging:

  • Clinical diagnosis requires two or more separate clinical readings demonstrating an elevated diastolic blood pressure ($\text{DBP} > 80\,\text{mm\,Hg}$) or systolic blood pressure ($\text{SBP} > 130\,\text{mm\,Hg}$).

  • Clinically recognized as the "silent killer" due to an absence of overt early clinical symptoms despite ongoing end-organ damage.

  • Five distinct hemodynamic categories:

  • Normal

  • Elevated Blood Pressure

  • Stage 1 Hypertension

  • Stage 2 Hypertension

  • Hypertensive Crisis

  • Etiological Classification:

  • Primary (Essential) Hypertension: Accounts for $95\%$ of all clinical cases; etiology remains idiopathic and multifactorial.

  • Secondary Hypertension: Accounts for $5\%$ of cases; attributable to identifiable underlying systemic pathologies (e.g., renal artery stenosis, Cushing's disease, pheochromocytoma).

• Epidemiology and Risk Factors:

  • Affects approximately one in every three adults across the United States.

  • Key risk factors include:

  • Advanced age.

  • Male sex.

  • African American ethnicity.

  • Obesity and excess body mass.

  • Genetic family history of essential hypertension.

  • Comorbid diabetes mellitus.

  • Tobacco use.

  • Excessive dietary sodium ($\text{Na}^+$) intake combined with low dietary potassium ($\text{K}^+$).

  • Chronic psychosocial stress.

  • Excessive alcohol consumption.

  • High basal renin secretion and hyper-responsiveness to circulating angiotensin II.

• Pathology and End-Organ Damage:

  • Hemodynamic Shearing Stress: Sustained high intraluminal pressure causes microscopic tearing of the delicate endothelial layer throughout systemic arterial networks.

  • Left Ventricular Hypertrophy (LVH):

  • The left ventricle faces persistent high afterload, forcing myocardial myocytes to hypertrophy to maintain stroke volume.

  • The hypertrophied, thickened left ventricular myocardium requires significantly greater coronary blood flow to satisfy its heightened metabolic oxygen demands.

  • Over time, relative ischemia develops as coronary supply cannot match demand, significantly raising the risk for myocardial infarction and congestive heart failure.

• Major Hypertensive Complications:

  • Left Ventricular Hypertrophy (LVH): Increased risk of ischemic heart disease, angina, and acute myocardial infarction (MI).

  • Aneurysm Formation: Weakened arterial walls bulge outward under continuous tension, predisposing vessels to lethal rupture.

  • Cerebral Hemorrhage: Rupture of fragile intracranial arterioles leading to hemorrhagic stroke.

  • Hypertensive Retinopathy: Progressive microvascular damage to retinal arterioles, leading to exudation, retinal hemorrhages, and visual impairment.

  • Renal Disease (Nephrosclerosis): Glomerular capillary wall sclerosis and ischemia, culminating in chronic kidney disease and end-stage renal failure.

Atherosclerosis Pathophysiology and Progression

• Etiology and Scope:

  • Atherosclerosis is an insidious, chronic inflammatory, and fibro-fatty disease of the arterial tunica intima.

  • Serves as the primary etiology of coronary artery disease (CAD), cerebrovascular accident (stroke), and peripheral arterial disease (PAD).

  • Risk factors: advanced age, male gender, diabetes mellitus, positive family history, smoking, hypertension, obesity, sedentary behavior, and saturated-fat diets.

• Step-by-Step Pathophysiological Sequence:

  • Endothelial Denudation and Injury: Mechanical shear stress, toxins, or hyperglycemia compromise the endothelial lining.

  • Leukocyte Recruitment: Damaged endothelium upregulates adhesion proteins, specifically vascular cell adhesion molecule 1 (VCAM-1) and monocyte chemoattractant protein-1 (MCP-1), drawing circulating white blood cells (monocytes and lymphocytes) into the subendothelial space.

  • Autoimmune and Inflammatory Response:

  • Monocytes differentiate into tissue macrophages.

  • Helper T lymphocytes respond aggressively against oxidized low-density lipoprotein (oxLDL).

  • B lymphocytes produce circulating antibodies against oxLDL particles.

  • Endothelial cells release von Willebrand factor (vWF), encouraging initial platelet adhesion.

  • Foam Cell Generation: Macrophages engulf excessive oxLDL particles through scavenger receptors until they become distended, lipid-rich foam cells.

  • Fatty Streak Formation: Foam cells aggregate within the tunica intima to produce gross, macroscopic lipid streaks; inflammatory cytokines release platelet-derived growth factor to recruit fibroblasts and smooth muscle cells.

  • Smooth Muscle Proliferation and Media Remodeling: Vascular smooth muscle cells migrate from the tunica media into the intima, proliferating and synthesizing collagen to construct an overlying fibrous cap.

  • Loss of Vasomotor Capacity: Smooth muscle hypertrophy combined with depleted endogenous nitric oxide synthesis severely restricts physiological vasodilation.

  • Plaque Calcification and Fibrous Cap Thinning: Over decades, the necrotic core accumulates calcium deposits, turning rigid and brittle.

  • Plaque Fissure, Rupture, and Embolization: Thinning of the fibrous cap permits superficial fissures to develop; mechanical disruption exposes the thrombogenic lipid core, driving rapid intraplaque hemorrhage, occlusive platelet thrombus formation, or distal thromboembolism.

• Diagnostic Biomarker: High-sensitivity C-reactive protein (hs-CRP) serves as an acute-phase inflammatory biomarker synthesized by the liver, correlating strongly with active arterial inflammation and progressive plaque instability.

Peripheral Arterial Disease and Arterial Ulcers

• Peripheral Arterial Disease (PAD):

  • Atherosclerotic narrowing affecting systemic arterial beds outside the cerebral and coronary vasculature.

  • The most frequent anatomic site of involvement is the femoral artery located proximal to the knee level.

  • Shares identical clinical risk factors with general atherosclerosis (HTN, dyslipidemia, diabetes, tobacco use, advanced age).

  • Characterized by an insidious, gradual onset; overt clinical symptoms typically emerge only after arterial lumen occlusion exceeds $70\%$.

  • Clinical physical examination must assess for multisite systemic arterial disease (evaluating for coexisting CAD, prior MI, carotid bruits, and impaired distal pulses).

• Intermittent Claudication:

  • The hallmark clinical symptom of peripheral arterial disease.

  • Characterized by reproducible cramping muscle pain, ache, or fatigue in the lower extremities brought on by physical exertion (e.g., walking) and promptly relieved by resting.

  • Mechanism: Fixed arterial stenoses prevent sufficient oxygenated blood delivery to working muscle during exercise; cellular metabolism switches to anaerobic glycolysis, generating excess lactic acid that irritates sensory pain fibers.

  • Cessation of exertion lowers muscle metabolic demand, matching oxygen delivery, clearing lactic acid, and relieving pain in classic ischemic (activity) and reperfusion (rest) cycles.

• Arterial Ulcers:

  • Ischemic necrotic skin wounds resulting from severe, uncorrected arterial hypoperfusion.

  • Clinical Features:

  • Extremely pale, dry, punched-out wound base.

  • Associated with cold extremities, diminished or absent peripheral pulses, loss of distal hair, shiny skin, and markedly delayed capillary refill ($>3\,\text{seconds}$).

  • Typical Anatomic Distribution:

  • Tips of the toes.

  • Heel of the foot.

  • Over the lateral malleolus of the ankle.

  • Requires strict preventive measures to avoid trauma and prevent deep osteomyelitis or limb gangrene.

Aneurysms, Aortic Dissection, and Vasculitis

• Arterial Aneurysms:

  • An abnormal, localized weakness and structural ballooning or dilation of an arterial vessel wall.

  • Predominant Anatomical Locations:

  • Cerebral Arteries: Small localized outpouchings located within the circle of Willis, frequently termed "berry aneurysms".

  • Aorta: The most common clinical manifestation is the Abdominal Aortic Aneurysm (AAA).

  • Etiology: Degenerative atherosclerotic damage eroding arterial medial elastic fibers; exacerbated by genetic connective tissue weakness, chronic infection, or vascular inflammation.

  • Major Rupture Risk Factors: Uncontrolled chronic hypertension, active cigarette smoking, and extensive atherosclerosis.

• Aortic Dissection:

  • A catastrophic, life-threatening emergency caused by a transverse tear in the tunica intima.

  • Pressurized pulsatile systemic blood enters the arterial wall, cleaving the tunica intima away from the tunica media and creating a dynamic "false lumen".

  • Clinical Presentation:

  • Abrupt, excruciating chest, back, or neck pain.

  • Classically described by the patient as a severe "ripping" or "tearing" physical sensation.

  • Associated with clinical pallor, diaphoresis, autonomic tachycardia, and wide blood pressure disparities between the upper extremities.

• Vasculitis (Arteritis):

  • Autoimmune or inflammatory destruction affecting blood vessels, classified systematically by internal vessel caliber:

  • Large-Sized Vasculitis:

    • Temporal Arteritis (TA, giant cell arteritis).

    • Takayasu Arteritis.

  • Medium-Sized Vasculitis:

    • Polyarteritis Nodosa (PAN).

    • Kawasaki Disease.

  • Small-Sized Vasculitis:

    • Raynaud's Disease (vasospastic disease affecting digital arterioles).

    • Thromboangiitis Obliterans (TAO, or Buerger's disease; associated with tobacco consumption).

Venous System Anatomy and Circulatory Hemodynamics

• Structural Characteristics of Veins:

  • Veins are thin-walled, distensible, low-pressure conduits tasked with returning deoxygenated blood back to the right atrium.

  • Function as systemic volume capacitance reservoirs, holding roughly two-thirds of total circulating blood volume at rest.

  • Contain unidirectional bicuspid semilunar valves engineered to direct blood upward toward the heart and prevent downward retrograde venous pooling.

  • Three-Layered Venous Wall:

  • Tunica Intima: Composed of a thin endothelial cell monolayer, elastic tissue, and folding valve leaflets.

  • Tunica Media: A thin, delicate layer of circular smooth muscle with far less contractile power than an arterial media.

  • Tunica Adventitia: A sturdy exterior fibrous layer of connective tissue.

• Venous Circulatory Networks:

  • Superficial Veins: Small-caliber veins located within subcutaneous adipose layers directly beneath the skin (e.g., great and small saphenous veins).

  • Deep Veins: Large-caliber veins traveling deep beneath the muscular fascia alongside major arteries (e.g., femoral, popliteal, iliac veins), draining directly into the inferior and superior venae cavae.

  • Perforating (Communicating) Veins: Transverse vascular bridges equipped with unidirectional valves that route blood flow exclusively from superficial veins into the deep venous system.

• Hemodynamic Mechanisms of Venous Return:

  • Because venous pressures are intrinsically low, the venous system cannot pump blood independently against the hydrostatic pull of gravity.

  • Venous return depends upon two vital mechanisms:

  • Skeletal Muscle Pump: Contraction of surrounding lower extremity skeletal muscles compresses thin venous walls, propelling blood cephalad.

  • Unidirectional Venous Valves: Close instantly during muscular relaxation to prevent gravitational backflow.

  • "Hardiness" of venous valves is an inheritable, familial genetic trait; structural weakness predisposes individuals to chronic venous insufficiency.

Venous Thromboembolism (DVT and Pulmonary Embolism)

• Venous Thromboembolism (VTE) Overview:

  • Encompasses the continuum of Deep Venous Thrombosis (DVT) and its severe sequela, Pulmonary Embolism (PE).

  • Deep vein thrombosis manifests predominantly within the deep veins of the calves, thighs, and pelvis.

  • Hospital admissions for VTE are escalating nationally, driven largely by wider use of sensitive diagnostic imaging modalities.

• Virchow's Triad:

  • The three fundamental pathophysiological pillars required for the formation of pathological venous thrombi:

  1. Venous Stasis: Sluggish, stagnant blood flow caused by prolonged immobility, long-distance travel, surgical anesthesia, or bed rest.

  2. Vessel Injury (Endothelial Trauma): Direct trauma, indwelling intravenous catheters, or orthopedic surgical intervention.

  3. Hypercoagulability: Prothrombotic hematologic states precipitated by malignancy, inherited factor deficiencies (e.g., Factor V Leiden), estrogen exposure, oral contraceptives, pregnancy, or dehydration.

• Pathophysiological Trajectory: DVT to Fatal Pulmonary Embolism (PE):

  • Step 1: In Situ Deep Venous Clot Formation: Stasis, endothelial injury, and hypercoagulability precipitate an occlusive thrombus in the deep veins of the lower extremity.

  • Step 2: Thromboembolus Propagation: A portion of the fragile venous clot dislodges, transforming into a circulating embolus that ascends rapidly through the common iliac vein into the inferior vena cava (IVC).

  • Step 3: Cardiopulmonary Occlusion: The embolus flows through the right atrium and right ventricle before being forcibly propelled into the main pulmonary artery.

  • The embolus wedges within the pulmonary arterial bed, obstructing pulmonary perfusion, causing acute ventilation-perfusion mismatch, right ventricular strain, and potential sudden death.

Chronic Venous Insufficiency, Varicose Veins, and Venous Ulcers

• Chronic Venous Insufficiency (CVI):

  • Results from persistent venous valvular incompetence in the deep or superficial venous channels.

  • Incompetent valves fail to prevent retrograde pooling, drastically elevating distal hydrostatic pressure.

  • Elevated hydrostatic pressure forces intravascular fluid across capillary walls into interstitial compartments, precipitating chronic lower-extremity edema and tissue ischemia.

  • Etiological Factors:

  • Genetic valve weakness.

  • May-Thurner Syndrome: Anatomic compression of the left common iliac vein by the overlying right common iliac artery against the lumbar spine.

  • Prior pelvic or limb trauma.

  • Obesity and pregnancy (inducing elevated intra-abdominal pressure that impedes pelvic venous drainage).

  • Prolonged occupational standing or sitting.

• Varicose Veins:

  • Also designated as varicosities; defined as abnormally dilated, tortuous, and elongated superficial veins.

  • Primarily affect superficial veins due to absent muscular fascial support compared to deep veins.

  • High gravitational hydrostatic pressure stretches the venous wall, pulling opposing valve leaflets apart and exacerbating valvular incompetence.

  • Epidemiology and Predisposition:

  • Incidence rises progressively with advanced chronological age.

  • Markedly higher prevalence among females (owing to progesterone-mediated smooth muscle relaxation and repeated pregnancies).

  • Amplified by obesity and professions requiring prolonged static standing.

• Venous Ulcers (Stasis Ulcers):

  • Indolent, chronic cutaneous wounds caused by sustained venous hypertension and severe venous insufficiency.

  • Primary Mechanism:

  • Sustained venous reflux and deep venous obstruction drive extreme ambulatory venous hypertension.

  • Capillary beds distend, allowing extravasation of red blood cells into surrounding interstitial dermis.

  • Breakdown of trapped red blood cells releases iron-laden hemosiderin pigment, staining the skin a characteristic dark brown/brawny color.

  • Subcutaneous tissues undergo lipodermatosclerosis and become hypoxic; trivial surface trauma or minor pressure triggers non-healing skin ulcerations.

  • Clinical Features and Location:

  • Typically shallow, irregularly shaped wounds with moist, exudative, dark-red granulation tissue.

  • Located proximally around the medial malleolus of the lower leg/ankle, contrasting sharply with the dry, pale, punched-out distal ulcers seen in arterial disease.